Magnolia Medical Technologies, Inc.
- UEI
- KE3DWGU9NQ95
- CAGE
- 6DNX7
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- magnolia-medical.com
- Founded
- 2006
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $57,952 |
| FY2023 | $56,952 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| BD GMBH | Heidelberg, BW | 339112 Surgical and Medical Instrument Manufacturing |
| Kandu Supplies And Services, LLC | San Antonio, TX | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| Accelerate Diagnostics, Inc. | — | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Meridian Bioscience Inc. | Cincinnati, OH | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Billing Office | Syracuse, NY | 621111 Offices of Physicians (except Mental Health Specialists) |
About the company
Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests. They have developed the Steripath Initial Specimen Diversion Device, which is designed to enhance the accuracy of blood culture testing.
Through prime federal contract awards, Magnolia Medical Technologies has provided various goods and services related to blood culture collection devices and supplies. The Department of Veterans Affairs has awarded multiple delivery orders to Magnolia for the provision of the Steripath device and associated supplies, such as a $50,794.80 order in 2022 and a previous $56,530.46 order in 2019-2020. Additionally, the Indian Health Service awarded a $247,512.00 firm-fixed-price purchase order contract for blood culture collection devices and supplies covering a base year plus four option years through January 2027. These contracts were not set aside for any specific business category.
Magnolia Medical Technologies holds a multiple award Federal Supply Schedule contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. This contract, with a potential value of $17,419,520.00 through March 31, 2029, aims to provide in vitro diagnostics, reagents, test kits, and test sets to support diagnostic testing needs across the VA healthcare system. It facilitates the procurement of products and services required for clinical pathology and laboratory medicine departments to perform diagnostic analyses that aid in disease screening, diagnosis, and treatment monitoring. Individual task orders will be used to fulfill specific product and service requirements under this contracting vehicle, enabling VA facilities to efficiently meet the diagnostic testing needs of veterans.
SBA capabilities narrative
Magnolia Medical Technologies produces a patented system to take blood samples for hematology lab tests that markedly reduces the rate of false positive results.
Quick answers
Is Magnolia Medical Technologies, Inc. registered in SAM.gov?
Magnolia Medical Technologies, Inc.'s SAM.gov registration expired on May 20, 2026.
What is Magnolia Medical Technologies, Inc.'s CAGE code?
Magnolia Medical Technologies, Inc.'s CAGE code is 6DNX7, and its Unique Entity ID (UEI) is KE3DWGU9NQ95.
Which contract vehicles does Magnolia Medical Technologies, Inc. hold?
Magnolia Medical Technologies, Inc. holds a place on 1 federal contract vehicle: FSS-65-VII.
How much has Magnolia Medical Technologies, Inc. received in federal contracts?
Federal contracts obligated $114,904 to Magnolia Medical Technologies, Inc. in fiscal years 2023 through 2027.
What is Magnolia Medical Technologies, Inc.'s most recent federal award?
Magnolia Medical Technologies, Inc.'s most recent federal contract award is Mpls steripath do- 6/1/22 to 9/30/22 (36C26322N0683), from Veterans Integrated Service Network 23 (VHA), on June 1, 2022.
On GovTribe
See Magnolia Medical Technologies, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors